Search for Clinical Trial Results
Hypophosphatemia - 68 Studies Found
Status | Study |
Completed |
Study Name: Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients Condition:
|
Recruiting |
Study Name: Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project. Condition: Autosomal Dominant Hypophosphatemic Rickets Date: 2014-08-27 Interventions: Dietary Supplement: Iron All subjects will receive iron supplementation based on iron levels in the bloo |
Completed |
Study Name: Growth Hormone Treatment in Children With Hypophosphatemic Rickets Condition: X Linked Hypophosphatemic Rickets Date: 2016-03-15 Interventions: Drug: norditropine simplex Other Name: growth hormone |
Completed |
Study Name: A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia Condition: X-linked Hypophosphatemic Rickets/Osteomalacia Date: 2014-07-02 Interventions: Drug: KRN23 Single SC administration on day 1: 0.3, 0.6 and 1.0 mg/kg |
Completed |
Study Name: Assessment Of Vitamin D Role In The Pathogenesis Of Asthma In Vitamin D Resistent Patients Condition:
Date: 2011-11-09 Interventions: Other: Methacholine Challenge Test Evaluation of airway hyperreactivity as assessed by doubling dose of |
Completed |
Study Name: Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets Condition:
Date: 2006-12-28 Interventions:
|
Active, not recruiting |
Study Name: Hypophosphatemic Rickets in Norway Condition:
|
Completed |
Study Name: Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4 Condition: Chronic Kidney Disease Date: 2008-10-01 Interventions:
|
Recruiting |
Study Name: Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH) Condition: X-Linked Hypophosphatemia Date: 2016-05-23 Interventions:
|
Active, not recruiting |
Study Name: Study of the Safety, Pharmacodynamics and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH) Condition: X-Linked Hypophosphatemia Date: 2015-12-06 Interventions: Drug: KRN23 |